Results 81 to 90 of about 191,188 (220)
Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction
Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey +7 more
wiley +1 more source
Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide
Islet amyloid polypeptide (IAPP, "amylin") is the amyloid-fibril-forming polypeptide in the islets of Langerhans associated with type 2 diabetes mellitus.
Nanjo, K +8 more
core
Amylin at the Interface between Metabolic and Neurodegenerative Disorders
The pancreatic peptide amylin is best known for its role as a satiation hormone in the control of food intake and as the major component of islet amyloid deposits in the pancreatic islets of patients with type 2 diabetes mellitus (T2DM).
Thomas Alexander Lutz, Urs eMeyer
doaj +1 more source
Translating gut microbiome research into therapies for type 1 diabetes
Abstract Type 1 diabetes (T1D) is characterised by the loss of functional pancreatic β‐cells, for which lifelong insulin therapy remains the standard of care. Given that the gut microbiome can influence host health and that shifts in gut microbial profiles have been observed in T1D, growing interest has emerged in the role of the gut microbiome in T1D,
Shanti P. Kok +2 more
wiley +1 more source
AIMS/HYPOTHESIS: Islet amyloid deposits are present in over 85% of Type 2 diabetic patients and have been suggested to be pathogenic. The mechanism that converts islet amyloid polypeptide (IAPP), the unique component of these deposits, into amyloid ...
Vidal, J. +10 more
core +1 more source
Polyphenol Interactions with Amyloid Fibrils: A Molecular Docking Study
Polyphenols, a versatile group of naturally occurring compounds with many favorable biological properties currently attract increasing research interest in the context of their ability to inhibit the formation and to destabilize special protein ...
Uliana Malovytsia +5 more
doaj +1 more source
Abstract Progressive β cell death resulting from the aggregation of human islet amyloid polypeptide (hIAPP) in the pancreas is a molecular driver of type 2 diabetes (T2D). Recent studies from our group have shown that hIAPP forms two distinct amyloid oligomers: on‐path donut oligomers (DOs) and off‐path round oligomers (ROs). Previous studies have also
Daniel Warren +3 more
wiley +1 more source
Amyloid-induced oxidative stress contributes to reduced islet cell viability but does not impact insulin ...
Jayalakshmi Udaya-Sankar (13348701) +4 more
core
Membrane-mediated amyloid deposition of human islet amyloid polypeptide [PDF]
Amyloid deposition of human islet amyloid polypeptide (hIAPP) within the islet of Langerhans is closely associated with type II diabetes mellitus. Accumulating evidence indicates that the membrane-mediated aggregation and subsequent deposition of hIAPP are linked to the dysfunction and death of insulin-producing pancreatic β-cells, but the molecular ...
openaire +2 more sources
Extensive amyloid formation in transplanted microencapsulated mouse and human islets
Objective: Deposition of cell toxic islet amyloid is a frequent finding in type 2 diabetes and also in transplanted human islets, where it is a possible explanation for their long-term failure.
Bohman, Sara,, Westermark, Gunilla,
core +1 more source

